Management of hepatitis B and C infections in rheumatologic disease

被引：3
作者：
Cheah, Jonathan T. L. [1 ]
Faragon, John J. [2 ]
Marks, Kristen M. [3 ]
机构：
[1] Hosp Special Surg, Dept Med, 535 E 70th St, New York, NY 10021 USA
[2] Albany Med Ctr, Dept Pharm & Med, 43 New Scotland Ave, Albany, NY 12208 USA
[3] Weill Cornell Med, Div Infect Dis, 525 East 70th St, New York, NY 10065 USA
来源：
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2018年 / 32卷 / 06期
关键词：
Hepatitis B; Hepatitis C; Vasculitis; Polyarteritis nodosa; Cryoglobulinemic vasculitis; Direct-acting antivirals; Sicca syndrome; Arthritis; Drug interactions; TENOFOVIR DISOPROXIL FUMARATE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HCV GENOTYPE 1; VIRUS-INFECTION; POLYARTERITIS-NODOSA; MIXED CRYOGLOBULINEMIA; SJOGREN-SYNDROME; SURFACE-ANTIGEN; EXTRAHEPATIC MANIFESTATIONS; ANKYLOSING-SPONDYLITIS;
D O I：
10.1016/j.berh.2019.04.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hepatitis B and C viruses present dual considerations in rheumatic disease as both etiologic factors and important comorbidities that must be assessed and addressed. This review summarizes the link between hepatitis B and arthritis and polyarteritis nodosa as well as hepatitis C and arthritis, Sicca syndrome and cryoglobulinemic vasculitis. Recent data pertaining to the antiviral management in these conditions, especially regarding the use of the direct-acting antivirals in hepatitis C, are also presented. Additionally, guidance on testing and treatment of hepatitis B and C as comorbidities in the context of systemic inflammatory rheumatic conditions and the use of disease-modifying antirheumatic therapy are discussed. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码：848 / 868
页数：21
相关论文
共 50 条
  • [1] Rheumatologic Manifestations of Hepatitis C Virus Infection
    Cacoub, Patrice
    Comarmond, Cloe
    Desbois, Anne Claire
    Saadoun, David
    CLINICS IN LIVER DISEASE, 2017, 21 (03) : 455 - +
  • [2] Rheumatologic manifestations of hepatitis C in the era of direct-acting antiviral agents
    Priora, Marta
    Realmuto, Cristina
    Parisi, Simone
    Ditto, Maria C.
    Borrelli, Richard
    Peroni, Clara L.
    Lagana, Angela
    Fusaro, Enrico
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2020, 66 (03) : 280 - 289
  • [3] Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease
    Khoo, Tiffany
    Lam, Danielle
    Olynyk, John K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (29) : 4831 - 4845
  • [4] Bone health in HIV and hepatitis B or C infections
    Biver, Emmanuel
    Calmy, Alexandra
    Rizzoli, Rene
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2017, 9 (01) : 22 - 34
  • [5] The management of hepatitis B and hepatitis C in children
    Batsis, Irini D.
    Wasuwanich, Paul
    Karnsakul, Wikrom W.
    MINERVA PEDIATRICA, 2019, 71 (01) : 59 - 75
  • [6] Update on the management of hepatitis B and C infections in the neonatal period
    Espinosa, Claudia M.
    Jhaveri, Ravi
    SEMINARS IN PERINATOLOGY, 2018, 42 (03) : 185 - 190
  • [7] Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease
    Sharma, Purva
    Sawtell, Rani
    Wang, Qiyu
    Sise, Meghan E.
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (04): : 343 - 355
  • [8] Immune disorders and rheumatologic manifestations of viral hepatitis
    Maslennikov, Roman
    Ivashkin, Vladimir
    Efremova, Irina
    Shirokova, Elena
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (18) : 2073 - 2089
  • [9] Vascular and glomerular manifestations of viral hepatitis B and C: a review
    Adeyi, Oyedele A.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2009, 26 (02) : 116 - 121
  • [10] HLA-DRB1 Polymorphisms and Rheumatologic Manifestations in Chronic Hepatitis C
    Medolago, Natalia Bronzatto
    Ferrasi, Adriana Camargo
    da Rocha, Oswaldo Melo
    Pardini, Maria Ines de Moura Campos
    Grotto, Rejane Maria Tommasini
    Silva, Giovanni Faria
    CURRENT RHEUMATOLOGY REVIEWS, 2023, 19 (01) : 58 - 63
12345